SR2211 is primarily utilized in research settings as a selective agonist for the nuclear receptor REV-ERB, which plays a crucial role in regulating circadian rhythms and metabolic processes. Its application is significant in studies focused on understanding the molecular mechanisms of circadian biology and its impact on various physiological functions, including sleep, metabolism, and inflammation. Researchers use SR2211 to explore potential therapeutic interventions for disorders related to circadian dysregulation, such as sleep disorders, metabolic syndromes, and certain inflammatory conditions. Additionally, it aids in investigating the role of REV-ERB in lipid and glucose metabolism, offering insights into the development of treatments for metabolic diseases like obesity and diabetes.